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Abstract
Urinary bladder activity involves central and autonomic nervous systems and bladder wall. Studies on the pathogenesis of voiding disorders
such as the neurogenic detrusor overactivity (NDO) due to suprasacral spinal cord lesions have emphasized the importance of an abnormal
handling of the afferent signals from urothelium and lamina propria (LP). In the LP (and detrusor), three types of telocytes (TC) are present and
form a 3D-network. TC are stromal cells able to form the scaffold that contains and organizes the connective components, to serve as guide for
tissue (re)-modelling, to produce trophic and/or regulatory molecules, to share privileged contacts with the immune cells. Specimens of full
thickness bladder wall from NDO patients were collected with the aim to investigate possible changes of the three TC types using histology,
immunohistochemistry and transmission electron microscopy. The results show that NDO causes several morphological TC changes without
cell loss or network interruption. With the exception of those underlying the urothelium, all the TC display signs of activation (increase in Cave-
olin1 and caveolae, aSMA and thin filaments, Calreticulin and amount of cisternae of the rough endoplasmic reticulum, CD34, euchromatic
nuclei and large nucleoli). In all the specimens, a cell infiltrate, mainly consisting in plasma cells located in the vicinity or taking contacts with
the TC, is present. In conclusion, our findings show that NDO causes significant changes of all the TC. Notably, these changes can be inter-
preted as TC adaptability to the pathological condition likely preserving each of their peculiar functions.
Keywords: bladder lamina propria detrusor immunohistochemistrymyofibroblasts transmission electron
microscopy aSmooth muscle actin Calreticulin Caveolin1 CD34 PDGFRa
Introduction
The urinary bladder activity is the result of complex interactions involv-
ing the central nervous system, the autonomic nervous system and the
bladder wall [1]. The human bladder wall, similarly to all the hollow
organs, is constituted by three main layers: (1) the smooth muscula-
ture (named detrusor); (2) the lamina propria (LP) incompletely divided
into two portions by an irregularly organized and discontinuousmuscu-
laris mucosae: a deep LP (DLP) or submucosa and an upper LP (ULP)
or suburothelium; (3) the surface epithelium (named urothelium).
Although the reservoir and the voiding functions depend on detru-
sor relaxation/contraction (together with opposite responses by the
urethral sphincters), respectively, the studies on voiding disorders
have progressively underlined the fundamental contribution of the
other two layers to bladder functionality. Two putative mechanisms
have been taken into account to explain the appearance of voiding
disorders: (1) an augmented efferent activity (the myogenic hypothe-
sis); (2) an abnormal handling of afferent signals (the urothelium-
suburothelium hypothesis) [2]. In particular, the urothelium is consid-
ered the sensory system that perceives the urine composition and the
hydrostatic pressure, and the suburothelium (properly the LP) repre-
sents an integrated system able to guarantee the arrival of the correct
information to the nerve centres [2, 3].
The LP hosts several types of cells immersed in an extracellular
matrix with a complex composition, a rich vascular web and numer-
ous nerve endings [3]. The cell distribution and density and the com-
position of the extracellular matrix have allowed distinguishing two
regions in the LP (see above), independently on the presence of a
muscularis mucosae [3]. Immunohistochemical and transmission
electron microscopy (TEM) studies of healthy human LP reported the
presence of different types of stromal cells whose nomenclature var-
ies among authors. Indeed, these cells were generically called
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interstitial cells (IC) or, more precisely, telocytes (TC) and myofibrob-
lasts [4–6]. Furthermore, the use of appropriate immunohistochemi-
cal labelling and the ultrastructural investigations allowed
distinguishing up to three different TC types [4, 6, 7]. Several roles
have been attributed to the TC. Starting from the common datum that,
everywhere, these cells form a 2- or 3D-network, it has been sup-
posed that they constitute the scaffold that keeps together and orga-
nizes the connective components (extracellular matrix, cells and
blood vessels). Moreover, TC scaffolds might guide the parenchymal
cells and/or their precursors to organize in tissues. Further, as these
cells show signs of exocytosis and form exosomes, they could be
involved in the production of extracellular molecules with trophic and/
or regulatory activities. TC also take privileged contacts with the
immune cells [for review see refs 8–10]. Finally, the possibility that
TC mediate neuronal responses has been reported [8, 11, 12].
Suprasacral spinal cord injuries of different aetiologies are at the
base of neurogenic detrusor overactivity (NDO), a clinical condition
characterized by involuntary detrusor contractions during the filling
phase causing urinary frequency, urgency and incontinence [2, 13].
Although the incontinence is due to anomalous detrusor contractions,
increasing evidences localize the mechanisms responsible for the
symptomatology in the urothelium and the underlying LP where
abnormal afferent signals would be processed [2]. The few morpho-
functional studies available show an increase in the LP cell number in
rats with spinal cord injury (SCI) [14], an increase in connexin
expression [15, 16] and a shift towards a fibroblast phenotype [4] in
the cells of the ULP, and an increase in the ULP thickness [17] in the
bladder of NDO patients. To note, all these studies have been
performed mainly in bioptic specimens at different stages of the dis-
ease, and all of them were focused on the ULP [4, 15–18]. Clinically,
the possibility to control incontinence is linked to the efficacy of two
types of drugs, the antimuscarinic and the botulinum toxin derived
molecules. Nevertheless, all the patients develop, sooner or later,
resistance to the drug efficacy and are forced to surgery intervention.
Although it is still matter of debate the exact functions that TC and
myofibroblasts play in regulating the afferent inputs to guarantee an
adequate bladder activity, it is a common convincement that changes
in these cells have a role in the pathogenesis of altered bladder func-
tionality such that present in NDO.
In the attempt to bring new data to this debate, we collected
samples of full thickness bladder wall from a group of NDO patients
comparatively homogenous for aetiology, length of the disease and clini-
cal course with the aim to investigate any morphological changes of the
three types of TC previously described in the human bladder by using
histological, immunohistochemical and ultrastructural methodologies.
Material and methods
Subjects and sample collection
A total of eight patients (four females, four males; mean age:
40  2.9 years) underwent to partial/total cystectomy or urinary diver-
sion (Table 1). All the patients had a NDO diagnosis due to the follow-
ing pathologies: SCI, multiple sclerosis (MS) and myelitis. The choice of
Table 1 Clinical data
Sex Pathology Site Age of spinal injury Age of surgery Years of drug treatment
Ctrl 1 Female Cancer – – 58 –
Ctrl 2 Male Cancer – – 69 –
Ctrl 3 Male Cancer – – 77 –
Ctrl 4 Male Cancer – – 74 –
Ctrl 5 Male Cancer – – 76 –
Ctrl 6 Male Cancer – – 78 –
Pt 1 Female SCI D8 31 44 13
Pt 2 Female SCI D5 25 36 11
Pt 3 Male Myelite D4 24 41 17
Pt 4 Female MS S-S** 36 52 16
Pt 5 Female SCI D8 29 45 16
Pt 6 Male SCI D8 29 47 18
Pt 7 Male SCI C6 28 35 7
Pt 8* Male SCI D4 18 25 7
Ctrl: control; Pt: patient; SCL: spinal cord injury; MS: multiple sclerosis. *Non-responder patient to botulinum toxin treatment. **Suprasacral.
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the surgery was carried out because the ongoing treatments with botuli-
num toxin injections into the detrusor and the anti muscarinic drugs
orally administered were no longer effective. In addition, the urodynamic
parameters, the possibility of urine reflux and personal reasons con-
curred to the surgery choice. A total of six patients (one females, five
males; mean age: 72  3 years) operated for bladder cancer repre-
sented the control group for the present work (Table 1). During the sur-
gical procedure, immediately after organ removal, full-thickness
specimens of the bladder lateral wall were obtained from each patient
cutting far from the macroscopic lesion and processed for histological,
immunohistochemical and TEM studies. All the patients gave written
informed consent and the local Ethical Committee approved the study
protocol.
Routine histology and Immunohistochemistry
The full-thickness specimens were fixed in 4% paraformaldehyde in
0.1 M phosphate-buffered saline (PBS, pH 7.4) over night (ON) at 4°C,
dehydrated in a graded ethanol series, cleared in xylene and embedded
in paraffin. The sections were cut (5 lm thick) using a rotary micro-
tome (MR2; Boeckeler Instruments Inc., Tucson, AZ, USA), collected on
positively charged slides and processed for either histological and
immunohistochemical labelling. The sections were deparaffinized and
rehydrated as usual. To evaluate the tissue organization, the sections
were stained with haematoxylin–eosin (H&E). For immunohistochemical
labelling, the sections were formerly boiled 10 min. in sodium citrate
buffer (10 mM, pH 6.0; Bio-Optica, Milan, Italy) or treated 20 min. at
90–92°C in Tris buffer (10 mM) with EDTA (1 mM, pH 9.0), as appro-
priate for antigen retrieval. After antigen retrieval phase, the sections
were washed in 0.1 M PBS, incubated in 2 mg/ml glycine (AppliChem,
Darmstadt, Germany) for 10 min. to quench autofluorescence caused
by the elastic fibres and blocked for 20 min. at room temperature (RT)
with 1.5% bovine serum albumin (BSA) in 0.1 M PBS. The primary anti-
bodies diluted in 0.1 M PBS were applied ON at 4°C. The day after, the
slides were washed in PBS and incubated for 2 hrs at RT in the dark
with appropriate fluorochrome-conjugated (Alexa Fluor 488-or 568-con-
jugated) secondary antibodies diluted 1:333 in 0.1 M PBS. Tissue sec-
tions were then thoroughly washed in PBS and mounted in an aqueous
medium (Sigma-Aldrich, St. Louis, MO, USA). For double labelling
experiments, after the first incubation as described above, the sections
were re-incubated with a diverse primary antibody and with the appro-
priate secondary antibody, following the same procedures. To exclude
the presence of non-specific immunofluorescence staining negative con-
trols were performed omitting the primary antibody and, for the M2r
antibody, using the relative blocking peptide (AMR-002-peptide; Alo-
mone Lab, Jerusalem, Israel). Information on primary and secondary
antibody sources and used concentrations is shown in Table 2. The
immunoreaction products were observed under an epifluorescence Zeiss
Axioskop microscope (Mannheim, Germany) using 488- and 568-nm
excitation wavelength for the green and red fluorescent labels, respec-
tively, and the fluorescence images were captured using a Leica
DFC310 FX 1.4-megapixel digital camera, equipped with the Leica
software application suite LAS V3.8 (Leica Microsystems, Mannheim,
Germany).
Transmission electron microscopy (TEM)
Specimens comprehensive of the urothelium plus the LP and specimens
comprehensive of the LP and the detrusor were fixed in Karnowsky
(8% paraformaldehyde in distilled water and 0.2 M PBS containing
0.055 g/l NaPO4 and 0.04 M Lysine, added with 0.5% glutaraldehyde)
ON at 4°C, post-fixed with 1% osmium tetroxide in 0.1 M PBS for
2 hrs at 4°C, dehydrated in graded series of acetone and embedded in
Epon by using flat moulds. Semi-thin sections were obtained with a
Table 2 List of the primary and secondary antibodies
Host IHC Producer
Primary antibody
anti-PDGFRa Goat 1:100 Catalogue n. AF-307-NA; R&D Systems, Minneapolis, MN, USA
anti-CD34 Mouse 1:50 Catalogue n. M7165; Dako, Glostrup, Denmark
anti-aSMA Mouse 1:500 Catalogue n. A-2547; Sigma-Aldrich, St. Louis, MO, USA
anti-Cav1 Mouse 1:200 Catalogue n. 610406; BD Transduction Labs, Lexington, KY, USA
anti-Calreticulin Chicken 1:200 Catalogue n. PA1-902A; Thermo Scientific, Runcorn, UK
anti-CD31 Rabbit 1:50 Catalogue n. ab28364; Abcam, Cambridge, UK
anti-M2r Rabbit 1:50 Catalogue n. AMR-002; Alomone Lab, Jerusalem, Israel
Secondary antibody
anti-Goat Donkey 1:333 Invitrogen, San Diego, CA, USA
anti-Mouse Goat 1:333 Jackson ImmunoReasearch Laboratories, West Grove, PA, USA
anti-Chicken Goat 1:333 Invitrogen, San Diego, CA, USA
anti-Rabbit Goat 1:333 Invitrogen, San Diego, CA, USA
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LKB NOVA ultra-microtome (Stockholm, Sweden), stained with a solu-
tion of toluidine blue in 0.1 M borate buffer and observed under a light
microscope to check the area of interest and the selected areas were
photographed. Then, ultra-thin sections (50/60 nm thick) of the selected
areas were cut using a diamond knife, stained with an alcoholic solution
of uranyl acetate in methanol (50:50) per 12 min. at 45°C followed by
an aqueous solution of concentrated bismuth subnitrate per 10 min. at
RT, examined under a JEOL 1010 electron microscope (Tokyo, Japan)
and photographed.
Quantitative analysis
The CD34 immunoreactive (IR) structures located in the DLP and detru-
sor were quantified using digitized images (four images/section; two
sections/patient) at 409 objective; attention was made to avoid overlap-
ping between adjacent portions. The quantitation was performed in dou-
ble labelled (CD34/CD31) sections to identify and exclude the
endothelial cells that express both markers. Each image was analysed
using ImageJ (NIH, Bethesda, ML, USA) to evaluate the intensity of
labelling and to quantify the area of the CD34+/CD31 structures. Each
photograph was converted to a binary image; the threshold value to
analyse the structures of interest exclusively was set in images from
the control patients and maintained in those of NDO patients. Results
were expressed as optical density  S.E.M.
The total PDGFRa+ TC and the PDGFRa+/aSMA+ TC located in the
ULP were counted using digitized images (10 images/section; two not
consecutive sections/two specimens/patient) at 1009 objective. In NDO
patients, the count was made only in the stratified areas. The non-
responder patient was excluded from quantitation. To photograph the
entire thickness of the ULP, two consecutive photographs along the ver-
tical axes were taken. Only PDGFRa+ cell bodies provided with at least
one process were counted in order to exclude other positive cells such
as mast cells and immune cells. Results were expressed as total num-
ber of PDGFRa+ TC, of PDGFRa+/aSMA+ TC and as a percentage of the
latter compared to the first  S.E.M.
Statistical analysis was performed using Prism 5.0 (GraphPad Soft-
ware, San Diego, CA, USA) and applying unpaired Student’s t-test to
compare the two groups. Differences were considered significant when
P < 0.05.
Results
In all the patients, the TC located in both LP and detrusor show
important immunohistochemical and structural changes compared to
controls.
Upper lamina propria (ULP)
This is the region that shows the most numerous and important mod-
ifications (Figs 1–6). In all the NDO patients, the ULP is thicker than
in controls (Figs 1, 2A–F, 5A, C and 6A, B) and, with the exception of
the non-responder patient (Figs 1D and 2C, F), is characterized by
alternation of small areas where, similarly to controls (Figs. 1A, B),
the cells are stratified and form a network with narrow meshes
(Figs 1C and 2B, E) and areas where the stratification is less evident
and the network has large meshes (Fig. 1C, E, F). These latter areas
are the most represented, and the meshes often contain a cell infil-
trate and/or an oedematous extracellular matrix (Figs 1C, E, F, 3A and
4A). The cell infiltrate is either diffuse or organized in large groups of
immune cells, most of which are plasma cells (Fig. 3A and inset),
surrounded by numerous capillaries (Fig. 1F). As in controls (Fig. 2A,
D, G, K), in the ULP of NDO patients two TC types can be identified by
immunohistochemistry: the PDGFRa+/aSMA-cells, the presumed typ-
ical TC, and the PDGFRa+/aSMA+ cells, the presumed hybrid TC
(Fig. 2B, C, E, F, H, I, J). Underneath the urothelium, the typical TC
are only PDGFRa+ and, together with blood capillaries (Figs 2K, I and
5B), form a continuous monolayer (Fig. 2A, D, G, K) that is perfectly
preserved in all the patients (Figs 2B, C, E, F, H, I and 5C, D). Beneath
this monolayer and in continuity with it, a cellular network is present.
In the controls, the ULP network is made by several rows of
cells oriented parallel to the urothelium. In each row, the cells
make contacts to each other end-to-end and, by means of perpen-
dicular processes, with the cells of the under- and upper-lying
rows leaving narrow spaces in between (Figs 1A, B and 2G). Mov-
ing towards the DLP, the cell rows progressively reduce this paral-
lel organization and the meshes of the net are larger. The two
types of TC previously described plus PDGFRa/aSMA+ cells iden-
tifiable as myofibroblasts make the ULP network (Fig. 2A, D). Both
TC types have a spindle-shaped body, an elongated and hete-
rochromatic nucleus and long and thin processes (Figs 1B and 2G,
K). Under the TEM, TC with the typical ultrastructural features
alternate with the hybrid TC, that are cells characterized by the
presence of small attachment plaques along their plasma mem-
brane [6]. Moreover, there are also cells identifiable as myofibrob-
lasts as having a large body rich in cisternae of the rough
endoplasmic reticulum (RER), a clear nucleus provided with a
prominent nucleolus and long attachment plaques (fibronexuses)
on the plasma membrane (data not shown).
In the NDO patients, in those areas apparently intact, the cells
forming the network are still organized in stratified rows but a minor-
ity of them are only PDGFRa+ while most of them also express aSMA
(Fig. 2B, C, E, F, I, J). Quantitation of the PDGFRa+ TC in the stratified
areas shows no difference between controls and NDO patients
(9.07  0.77 versus 10.97  0.96). On the contrary, the number of
the PDGFRa+/aSMA+ TC (5.93  0.6 versus 8.29  0.84) as well as
the percentage of these double labelled TC respect to the total TC
(0.64  0.03 versus 0.76  0.03) show a statistically significant
increase in NDO patients. In the infiltrated and oedematous areas, the
network is present and still made by the two TC types as in controls.
Independently of the area where are located, all the TC have as in con-
trols (Fig. 1B) long and thin processes oriented parallel and perpen-
dicular to the urothelium and contacting to each other, but many of
them have a large/oval body and a round/oval euchromatic nucleus
provided with a prominent nucleolus (Figs 3A and 4A). Moreover, in
the NDO patients, all the TC are richer in Cav1 than in controls
(Fig. 5). In the non-responder patient, the ULP network is particularly
thick and forms narrow meshes (Figs 1D, and 2C, F). The upper por-
tion of this network is made by several rows of only PDGFRa+/
aSMA TC and the lower portion by many rows of mainly PDGFRa+/
aSMA+ TC (Fig. 2C, F, J).
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Under the TEM, many of the typical TC, especially those close to
or contacting the immune/plasma cells, contain several RER cisternae
in the body and processes and numerous caveolae (Fig. 3B–D). To
note, in all the patients, there are no cells closely resembling the
hybrid TC described in controls, while, especially in the lower portion
of the ULP, where the PDGFRa+/aSMA+ cells are predominant, there
are cells that have a large and oval body, a round/oval euchromatic
nucleus with a prominent nucleolus, a clear cytoplasm and thin and
long processes by which they contact with each other (Fig. 4B, C).
The cytoplasm of these cells contains many sparse thin filaments and
along the plasma membrane numerous caveolae and attachment pla-
ques (Fig. 4B, C). Some of these features are similar to those of
myofibroblasts, but differently from the latter, these cells are poor in
RER cisternae; therefore, we consider them as modified hybrid TC. In
favour of this identification, myofibroblasts are still present and show
no significant changes either in their aSMA+ or in TEM features (data
not shown).
In all the patients, as in controls, the CD34+ is detected only on
the endothelial cells (Fig. 6A, B). Thus, the blood vessels are clearly
recognizable and appear hyperaemic, in particular the capillaries
immediately located underneath the urothelium (Fig. 6B).
None of the two ULP TC types expresses the M2r.
Deep lamina propria (DLP) and detrusor
In these regions, there is a single TC population that, both in the patients
and controls, is CD34+/PDGFRa/aSMA and forms a network in conti-
nuity with that in the ULP (Fig. 6C, D). In all the patients, these TC show
a larger cell size (Fig. 6E, F). Quantitation of the CD34+/CD31 struc-
tures in the DLP and detrusor displays a significant increase of the
CD34 labelling in both regions (Fig. 7). Moreover, in the TC located
within the detrusor, the Calret labelling is distributed in the entire cell
body and processes (Fig. 8A–D). Under the TEM, these TC show an
extended RER (Fig. 8E, F) and many caveolae (Fig. 8F). Finally, their
processes often embrace bundles of collagen fibrils (Fig. 8E).
None of the DLP and detrusor TC expresses the M2r.
Urothelium
Both in controls and patients, the urothelium is M2r+. The labelling is
distributed along the plasmalemma of the urothelial cells with an
increasing intensity from the superficial to the deeper cell layers. In
the NDO patients, the intensity of the labelling is globally decreased




Fig. 1 Upper lamina propria (ULP). H&E.
(A, B) controls. Several rows of cells with
an oval body and long, thin processes ori-
ented parallel to the urothelium are strati-
fied and form a network with narrow
meshes. (C–F) NDO patients. The ULP is
thicker than in controls: compare A with C
and D. In (C) alternation of small areas
where the cells are stratified and, as in
controls, form a network with narrow
meshes (asterisk) and areas where the
stratification is less evident and the net-
work has large meshes (double asterisks);
in between a large group of immune cells
(arrow). (D) non-responder patient. The
ULP is thicker than in controls and in all
other patients (compare with A and C)
and the cellular rows are close to each
other leaving a narrow space in between.
(E) the ULP network has large meshes
containing a cell infiltrate and a clear
(oedematous) extracellular matrix. The
thin TC processes clearly make a network
by contacting with each other. (F) the cell
infiltrate is organized in large groups of
immune cells, most of which are plasma
cells, surrounded by numerous capillaries.
Numerous and hyperemic capillaries are
also visible under the urothelium. DLP:
deep lamina propria; D: detrusor. Calibra-
tion bar: A, C, D = 100 lm; B,
E = 25 lm; F = 50 lm.
ª 2017 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
199
J. Cell. Mol. Med. Vol 22, No 1, 2018
Discussion
The present findings demonstrate that the three TC types described in
the control human bladder are still present in the NDO patients and
have a similar distribution. However, all these TC show morphological
changes. The two types located in the ULP, the PDGFRa+/aSMA and
the PDGFRa+/aSMA+ ones, display features of activation. Indeed,







Fig. 2 Upper lamina propria (ULP). PDGFRa (green) and aSMA (red) labelling. (A, D, G, K) controls. The ULP is made by several rows of cells.
Those forming the first row immediately beneath the urothelium are PDGFRa+/aSMA and form a continuous monolayer. The lower rows are made
by PDGFRa+/aSMA and PDGFRa+/aSMA+ cells. Asterisks in A indicate three myofibroblasts. (B, C, E, F, H, I, J) NDO patients. The suburothelial
layer is maintained in all the patients. In the non-responder patient, the ULP is very thick (C, F) and the upper portion is made by several rows of
PDGFRa+/aSMA cells while those located in the lower portions are mainly PDGFRa+/aSMA+ (C, F, J). U: urothelium. DLP: deep lamina propria.
Calibration bar: A–C = 100 lm; D–F = 50 lm; G, H = 25 lm; K–J = 10 lm.
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and the latter have a euchromatic nucleus carrying a large nucleolus, a
clear cytoplasm rich in thin filaments and several caveolae. Both cell
types share extended areas of contacts. Moreover, while the TC under-
lying the urothelium maintains immunohistochemical properties similar
to controls, the other TC are richer in Cav1 and, in the stratified areas,
the majority of them also express aSMA. The CD34+/PDGFRa/
aSMA cells, that are the TC located in the DLP and in the detrusor,
also show signs of activation such as an increase of CD34+, a large
body associated with an intracytoplasmatic Calret positivity and numer-
ous RER cisternae; moreover, the intramuscular TC own many caveo-
lae. All the NDO patients display a cell infiltrate mainly consisting in
plasma cells and lymphocytes either sparse or grouped. The plasma
cells are constantly located in the vicinity of the TC and often taking
close contacts with them. Remarkably, none of the TC modifications
A B
C D
Fig. 3 Upper lamina propria (ULP). Typical
TC, NDO patients. (A) semithin section,
toluidine blue stained. An area of the TC
network made by regularly stratified cells.
Many of these TC have an oval body and
long and thin processes. Numerous
immune cells (asterisks), many of which
are close to the TC, are present. Inset in
A: Detail of one plasma cell (asterisk) con-
tacting a TC. (B–D) transmission electron
microscopy. The cells identifiable as typi-
cal TC for their small oval body and long
and thin processes share numerous RER
cisternae in the body and processes (ar-
rows). These TC are often near or make
contacts (asterisks) (C, D) with the
immune cells. U: urothelium; PC: plasma
cell; L: lymphocyte; TC: telocyte. Calibra-
tion bar: A = 25 lm; Inset A = 10 lm;




Fig. 4 Upper lamina propria (ULP). Hybrid
TC, NDO patients. (A) semithin section,
toluidine blue stained. The TC processes
clearly make a network by contacting with
each other. Numerous cells, especially
those located in the deepest ULP portion
and identifiable as hybrid TC, have a large
and oval body, a round/oval euchromatic
nucleus with a prominent nucleolus, a
clear cytoplasm, and thin and long pro-
cesses. (B, C) transmission electron
microscopy. The presumptive hybrid TC
have an abundant cytoplasm containing
sparse, thin filaments, several attachment
plaques (asterisks) and many caveolae
along the plasma membrane. Arrows indi-
cate the cell-to-cell contacts with the pro-
cesses of other TCs. U: urothelium; hTC:
hybrid telocyte. Calibration bar:
A = 25 lm; B = 0.5 lm; C = 0.3 lm.
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A B
C D
Fig. 5 Upper lamina propria (ULP). (A–D
and inset in B) Cav1 (red) and PDGFRa
(green) labelling. Compared to controls
(A, B), the NDO patients (C, D) show TC
richer in Cav1. Inset (B) detail of the Cav1
and PDGFRa distribution in a TC. Aster-
isks indicate blood capillaries whose
endothelium is Cav1+ (B, D). U: urothe-
lium; Calibration bar: A, C = 50 lm; B,




Fig. 6 Lamina propria and detrusor. CD34
labelling. (A, C, E) controls; (B, D, F) NDO
patients. In the ULP the endothelial cells
only are CD34+ (A, B), while in the DLP
and detrusor also the TC are CD34+ (C–F).
(E, F) details of the DLP-TC in controls
(E) and in the NDO patients (F). U:
urothelium. ULP: upper lamina propria;
DLP: deep lamina propria; D: detrusor.
Calibration bar: A–D = 50 lm; E,
F = 25 lm.
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indicates degenerative features; rather, these changes suggest a sort
of TC adaptation to the pathological environment.
At least two main types of connective tissue cells have been
described in the LP of human bladder, the so-called myofibroblasts
[19] and a second population whose identity is still matter of debate.
In the attempt to overcome this nomenclature problem, many authors
have chosen to call ‘interstitial cells’ (IC) all the stromal cells. In our
opinion, this definition is too generic and also improper as the inter-
stitium is the space that separates parenchymal structures while the
LP cells reside in a complex matrix made by macromolecules and fib-
rils and the cells and the matrix, altogether, are responsible for the
tissue properties. To solve this problem, we named the stromal cells
currently investigated ‘myofibroblasts’ and ‘TC’ on the basis of their
ultrastructural features.
NDO is a complex pathology greatly compromising the patient
social life. The drugs commonly used to control the overactivity are
the antimuscarinic one and the botulin toxins, usually administered in
this temporal order. Nevertheless, after a variable period of years (in
our case the mean is 13.1  1.5), all the patients become insensitive
to these drugs, return incontinent and are forced to surgery interven-
tion. In NDO pathogenesis, a main role is attributed to bladder alter-
ation in handling the afferent signals and the urothelium and the LP
would play the bulk of this function. In particular, the urothelium
would act as a sensor perceiving chemical and mechanical stimuli
generated in the lumen and in releasing several molecules, such as
the Ach, in the extracellular spaces and in the underlying LP. In agree-
ment with the literature data [20, 21], we find the M2r not only on
smooth muscle cells but also on the urothelium, both in controls and
NDO patients (see Fig. S1). Interestingly, in the latter, the expression
of this receptor is reduced. This decrease could be due to an excess
of ACh production by the urothelium that, in the NDO patients, would
develop a condition of hyper-excitability to local stimuli [13, 22]. Still
in accordance with the literature, we detect no M2r labelling on the TC
and myofibroblasts either in controls or in NDO patients [2].
Noteworthy, in all the NDO patients, the TC forming the monolayer
laying the urothelium show features comparable to those of controls.
This TC population is quite peculiar either for location or for immuno-
labelling properties being PDGFRa+/aSMA/CD34. Cells with similar
immunohistochemical properties have been described immediately
beneath the intestinal epithelium [11, 23], and it has been hypothe-
sized that these cells could have a role in controlling the proliferation
and differentiation of the overlying epithelium and in maintaining the
mucosal homeostasis [23]. We believe that in the bladder these TC
could play similar functions. In favour of this possibility are: (i) the
site of location, (2) the expression of the PDGFRa, the receptor for
the platelet derived growth factor that is a major mitogen for many
mesenchymal cell types [24], (3) the several findings supporting a
Fig. 7 Quantitation of CD34+/CD31 in the deep lamina propria and
detrusor. The measurements are made in CD34/CD31 double labelled
sections and the results concern the only CD34+/CD31 labelled struc-
tures, that is i.e. the TC. The labelling, expressed as Optical Density is




Fig. 8 Detrusor. Immunohistochemistry.
(A, B) Calret (green) and aSMA (red)
labelling. In controls (A) and NDO patients
(B) the smooth muscle cells express both
markers while the TC (arrowheads)
express only Calret. (C, D) Calret (green)
and CD34 (red) labelling. In controls (C)
and NDO patients (D), the smooth muscle
cells express only Calret while TC express
both markers (arrowheads). In NDO
patients, the cells identifiable as TC are
richer in Calret. Transmission electron
microscopy. (E, F) NDO patients. The TC
are rich in RER cisternae and caveolae. In
(E), the TC processes embrace bundles of
collagen fibrils (asterisks). SMC: smooth
muscle cells. Calibration bar: A–
D = 25 lm; E = 1.6 lm; F = 0.5 lm.
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role for the TC in regeneration and differentiation of various organs
and tissues [25, 26]. In summary, the possibility that these TC also
play role(s) distinct from those attributed to the other TC types is
likely. As mentioned before, and at variance with all the others, in the
NDO patients and in our experimental conditions, these TC show no
sign of change. We do not have a definitive explanation for this find-
ing. It could be stressed that their location spare these TC from the
consequences of the local damages caused by the cell infiltrate.
Moreover, if these TC are engaged in cell proliferation and differentia-
tion of the overlying epithelium, the absence of cell death signs in
NDO might constitute a further explanation. However, it cannot be
excluded the possibility that other changes presently not ascertained
occur in these TC.
In the ULP of all the NDO patients, the complex network
made up by typical and hybrid TC and myofibroblasts and its
continuity with the suburothelial monolayer are conserved. How-
ever, because of the presence of the cell infiltrate and oedema,
this network is distended and forms large meshes. Intriguingly,
most of the immune cells consist of plasma cells. These cells
are constantly located in the proximity to the TC and establish
contact areas mainly with the typical TC. Cell-to-cell contacts
and presence of small vesicles (exosomes) in the narrow
spaces between TC and immune cells have been described and
the possibility that TC have a role in immune-regulation and
immune-surveillance has been considered [8, 27, 28]. In brief,
the TC by exocytosis vesicles could release soluble chemo-
attractant molecules, by their long processes act as guides for
immune cells, and by their contacts and exosomes production
present tissue derived antigens to the immune cells [27]. It has
been hypothesized that in the NDO, the loss of botulinum toxin
efficacy might be due to the development of an immune
response consisting in the production of antibodies against the
drug and/or its excipients [29]. The great number of plasma
cells, their constant vicinity to the TC and the high frequency of
the cell-to-cell contacts between these two cell types found in
our patients could be reasonably interpreted as the morphologi-
cal evidences of the above-mentioned hypothesis and support a
main role of the TC in mediating this immune response. If so,
also the signs of cell activation found in the typical TC of the
ULP, especially the richness in RER cisternae and caveolae,
could be easily explained.
Pointedly, although the TC are engaged in this immune regulation
activity and in spite of the presence of an abundant infiltrate, their net-
work seems neither lost nor interrupted in NDO. This 3D scaffold,
which extends to the detrusor, guarantees the structural integrity of
the bladder wall following the organ distension and relaxation and
avoids anomalous wall deformation [6]. The maintenance in the
patients of this integrity points out the great compliance of the TC in
adapting to tissue changes (damages). In particular, the peculiar fea-
tures of the hybrid TC (i.e. the euchromatic nucleus, the large nucleo-
lus, the numerous thin filaments) testify for an enhanced synthetic
activity likely aimed to the network preservation. Finally, the presence
of the extended cell-to-cell contacts we found between hybrid and
typical TC and the increase in Cox43 expression reported in NDO [15]
further support this TC adaptability.
Functionally, in control conditions, the TC, the myofibroblasts
and the numerous nerve endings of the ULP are able to respond
to molecules released from the urothelium and behave as an inte-
grated system whose interactions generate afferent stimuli regulat-
ing the micturition reflex [2, 3, 30, 31]. Likely, the efficiency of
this system also depends on the intercellular distances. Our and
similar studies [4, 17] have shown a constant increase in the ULP
thickness in the NDO patients without a significant increase in cell
number. Thus, this increased thickness should cause an augmen-
tation in the intercellular distances, which, in turn, would affect
the ULP functional integrity.
The so-called non-responder patient represents a case apart.
Indeed, in this patient, the marked increase of the ULP thickness is
associated with an unusual stratification characterized by numerous
rows of only PDGFRa+ cells in its upper portion and numerous rows
of mainly PDGFRa+/aSMA+ cells in the deeper portion. Clinically, this
patient presents two peculiarities: the youngest age and the refractori-
ness to botulinum-toxin treatment. Whether these conditions (and/or
others unknown) are responsible for this peculiar TC organization,
needs further investigations.
The increase in TC expressing aSMA+ present in the stratified
areas of all the patients might be interpreted as a shift versus a myofi-
broblast phenotype. Indeed, this possibility has already been reported
for TC [4, 17, 32, 33] but the lack of a RER increase and the mainte-
nance of the PDGFRa+ exclude similar trans-differentiations in our
specimens.
In the DLP as well as in the detrusor, the TC show signs of activa-
tion similar to those described in the TC located in the ULP and main-
tain the network integrity. Noteworthy, the increase in the cell size
associates with an increase in the expression of CD34 and Calret. While
the former could be interpreted as the consequence of an increased cell
membrane extension, the latter finding is quite intriguing and invites to
some speculations on its possible significance. Calret is a complex pro-
tein located in the RER, in the nucleus and along the nuclear envelope
[34]. It acts as chaperon to allow protein folding in the RER but it is
also considered a calcium binding protein [35]. Keeping in mind some
of the roles attributed to the TC, such as the iuxta/paracrine activity, the
ability to remodel the collagen fibrils and to control tissue homeostasis
[8], it could be speculated that the increased expression of Calret (and,
likely, other markers presently not investigated) represents a potentia-
tion of these functions. This possibility is particularly significant consid-
ering that this Calret increase happens in the TC located in the
detrusor, a compartment of the NDO bladder that shows signs of sev-
ere anomalies of both smooth muscle cells and extracellular matrix
(personal observations). In this regard, the existence of a functional
interaction between TC and smooth muscle cells has been already
reported in the uterus [36].
Briefly, the present results show that NDO causes significant
changes of all the three TC types present in the human bladder.
Importantly, these changes indicate a functional TC activation
without cell loss or interruption of the 3D-stromal scaffold present
within the entire bladder wall. Therefore, it can be concluded that
all the TC are able to resist to this pathological condition and that
their changes are signs of adaptability, likely preserving their
peculiar roles.
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Figure S1 Urothelium and detrusor. M2r labelling. (A, B) Urothelium.
In controls (A), the labelling is distributed along the plasmalemma
with an increasing intensity from the superficial to the deeper cell lay-
ers. In the NDO patients (B), the intensity of the labelling is globally
decreased but maintains the same distribution as in controls. (C)
Urothelium. M2r labelling after pre-adsorption with the blocking pep-
tide (BP). (D) Detrusor. M2r labelling. The M2r labelling is present on
the smooth muscle cells. Calibration bar: A–D = 25 lm.
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